Protein kinases: Evolution of dynamic regulatory proteins

Trends in Biochemical Sciences

Volumn 36, Issue 2, 2011, Pages 65-77

  Taylor, Susan S ^a   Kornev, Alexandr P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE PHOSPHATASE SHP;

CATALYSIS; DNA HELIX; ENZYME ACTIVATION; EUKARYOTIC CELL; HUMAN; HYDROPHOBICITY; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; EUKARYOTIC CELLS; EVOLUTION, MOLECULAR; HUMANS; MODELS, MOLECULAR; PROTEIN KINASES; SIGNAL TRANSDUCTION;

EUKARYOTA;

EID: 79551594605     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2010.09.006     Document Type: Review

References (60)

1. Krebs E.G. An accidental biochemist. Annu. Rev. Biochem. 1998, 67. xii-xxxii.
2. Walsh D.A., et al. An adenosine 3',5'-monophosphate-dependant protein kinase from rabbit skeletal muscle. J. Biol. Chem. 1968, 243:3763-3765.
3. Hunter T. Tyrosine phosphorylation: thirty years and counting. Curr. Opin. Cell Biol. 2009, 21:140-146.
4. Barker W.C., Dayhoff M.O. Viral src gene products are related to the catalytic chain of mammalian cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. U. S. A. 1982, 79:2836-2839.
5. Hanks S.K., Hunter T. Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 1995, 9:576-596.
6. Manning G., et al. Evolution of protein kinase signaling from yeast to man. Trends Biochem. Sci. 2002, 27:514-520.
7. Knighton D.R., et al. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 1991, 253:407-414.
8. Knighton D.R., et al. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 1991, 253:414-420.
9. Kannan N., Neuwald A.F. Did protein kinase regulatory mechanisms evolve through elaboration of a simple structural component?. J. Mol. Biol. 2005, 351:956-972.
10. Kannan N., et al. Structural and functional diversity of the microbial kinome. PLoS Biol. 2007, 5:e17.
11. Kornev A.P., et al. Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:17783-17788.
12. Kornev A.P., et al. A helix scaffold for the assembly of active protein kinases. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14377-14382.
13. Shudler M., Niv M.Y. BlockMaster: partitioning protein kinase structures using normal-mode analysis. J. Phys. Chem. A. 2009, 113:7528-7534.
14. Tsigelny I., et al. 600 ps molecular dynamics reveals stable substructures and flexible hinge points in cAMP dependent protein kinase. Biopolymers 1999, 50:513-524.
15. Madhusudan, et al. Crystal structure of a transition state mimic of the catalytic subunit of cAMP-dependent protein kinase. Nat. Struct. Biol. 2002, 9:273-277.
16. Ramakrishnan C., et al. A conformational analysis of Walker motif A [GXXXXGKT (S)] in nucleotide-binding and other proteins. Protein Eng. 2002, 15:783-798.
17. Johnson D.A., et al. Dynamics of cAMP-dependent protein kinase. Chem. Rev. 2001, 101:2243-2270.
18. Narayana N., et al. Crystal structure of a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein kinase complexed with the peptide inhibitor PKI(5-24) and adenosine. Biochemistry 1997, 36:4438-4448.
19. Steichen J.M., et al. Global consequences of activation loop phosphorylation on protein kinase A. J. Biol. Chem. 2010, 285:3825-3832.
20. Yang J., et al. Allosteric network of cAMP-dependent protein kinase revealed by mutation of Tyr204 in the P+1 loop. J. Mol. Biol. 2005, 346:191-201.
21. Deminoff S.J., et al. Distal recognition sites in substrates are required for efficient phosphorylation by the cAMP-dependent protein kinase. Genetics 2009, 182:529-539.
22. Huse M., Kuriyan J. The conformational plasticity of protein kinases. Cell 2002, 109:275-282.
23. Scheeff E.D., Bourne P.E. Structural evolution of the protein kinase-like superfamily. PLoS Comput. Biol. 2005, 1:e49.
24. Akamine P., et al. Dynamic features of cAMP-dependent protein kinase revealed by apoenzyme crystal structure. J. Mol. Biol. 2003, 327:159-171.
25. Adams J.A. Kinetic and catalytic mechanisms of protein kinases. Chem. Rev. 2001, 101:2271-2290.
26. Valiev M., et al. Phosphorylation reaction in cAPK protein kinase-free energy quantum mechanical/molecular mechanics simulations. J. Phys. Chem. B 2007, 111:13455-13464.
27. Adams J.A. Activation loop phosphorylation and catalysis in protein kinases: Is there functional evidence for the autoinhibitor model?. Biochemistry 2003, 42:601-607.
28. Johnson L.N., Lewis R.J. Structural basis for control by phosphorylation. Chem. Rev. 2001, 101:2209-2242.
29. Masterson, L.R. et al. (2010) Dynamics connect substrate recognition to catalysis in protein kinase A. Nat. Chem. Biol. doi:10.1038/nchembio.452.
30. Hubbard S.R., et al. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 1994, 372:746-754.
31. Yang J., et al. Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Mol. Cell 2002, 9:1227-1240.
32. Levinson N.M., et al. Structural basis for the recognition of c-Src by its inactivator Csk. Cell 2008, 134:124-134.
33. Shan Y., et al. A conserved protonation-dependent switch controls drug binding in the Abl kinase. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:139-144.
34. Brown N.R., et al. Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity. J. Biol. Chem. 1999, 274:8746-8756.
35. Xu W., et al. Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol. Cell 1999, 3:629-638.
36. Liu Y., et al. A molecular gate which controls unnatural ATP analogue recognition by the tyrosine kinase v-Src. Bioorg. Med. Chem. 1998, 6:1219-1226.
37. Zuccotto F., et al. Through the " gatekeeper door": exploiting the active kinase conformation. J. Med. Chem. 2010, 53:2681-2694.
38. Tamborini E., et al. A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient. Gastroenterology 2004, 27:294-299.
39. Azam M., et al. Activation of tyrosine kinases by mutation of the gatekeeper threonine. Nat. Struct. Mol. Biol. 2008, 15:1109-1118.
40. Daub H., et al. Strategies to overcome resistance to targeted protein kinase inhibitors. Nat. Rev. Drug Discov. 2004, 3:1001-1010.
41. Atwell S., et al. A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase. J. Biol. Chem. 2004, 279:55827-55832.
42. Thompson E.E., et al. Comparative surface geometry of the protein kinase family. Protein Sci. 2009, 8:2016-20126.
43. Jeffrey P.D., et al. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 1995, 376:313-320.
44. Filippakopoulos P., et al. Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation. Cell 2008, 134:793-803.
45. Anjum R., Blenis J. The RSK family of kinases: emerging roles in cellular signalling. Nat. Rev. Mol. Cell Biol. 2008, 9:747-758.
46. Kannan N., et al. The hallmark of AGC kinase functional divergence is its C-terminal tail, a cis-acting regulatory module. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:1272-1277.
47. Dixit A., Verkhivker G.M. Hierarchical modeling of activation mechanisms in the ABL and EGFR kinase domains: thermodynamic and mechanistic catalysts of kinase activation by cancer mutations. PLoS Comput. Biol. 2009, 5:e1000487.
48. Romano R.A., et al. A chimeric mechanism for polyvalent trans-phosphorylation of PKA by PDK1. Protein Sci. 2009, 18:1486-1497.
49. Dar A.C., et al. Higher-order substrate recognition of eIF2α by the RNA-dependent protein kinase PKR. Cell 2005, 122:887-900.
50. Kim C., et al. PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation. Cell 2007, 130:1032-1043.
51. Wu J., et al. PKA type IIα holoenzyme reveals a combinatorial strategy for isoform diversity. Science 2007, 318:274-279.
52. Torkamani A., et al. Congenital disease SNPs target lineage specific structural elements in protein kinases. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9011-9016.
53. Manning G., et al. The protein kinase complement of the human genome. Science 2002, 298:1912-1934.
54. Xu B., et al. WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J. Biol. Chem. 2000, 275:16795-16801.
55. Mukherjee K., et al. CASK functions as a Mg2+-independent neurexin kinase. Cell 2008, 133:328-339.
56. Scheeff E.D., et al. Structure of the pseudokinase VRK3 reveals a degraded catalytic site, a highly conserved kinase fold, and a putative regulatory binding site. Structure 2009, 17:128-138.
57. Fukuda K., et al. The pseudoactive site of ILK is essential for its binding to α-Parvin and localization to focal adhesions. Mol. Cell 2009, 6:819-830.
58. Labesse G., et al. ROP2 from Toxoplasma gondii: A virulence factor with a protein-kinase fold and no enzymatic activity. Structure 2009, 17:139-146.
59. Zeqiraj E., et al. Structure of the LKB1-STRAD-MO25 complex reveals an allosteric mechanism of kinase activation. Science 2009, 326:1707-1711.
60. Suel G.M., et al. Evolutionarily conserved networks of residues mediate allosteric communication in proteins. Nat. Struct. Biol. 2003, 10:59-69.